Диссертация (Свободные и координированные ионами Pt(II), Pd(II) тетразолилуксусные кислоты как перспективные скаффолды в синтезе новых биологически активных веществ), страница 20

ACS Med. Chem. Lett., 2012, 3, 177−181.85. Lu, Y.; Chen, J.; Xiao, M.; Li, W.; Miller, D.D. An Overview of TubulinInhibitors That Interact with the Colchicine Binding. Site Pharm. Res., 2012,29(11), 2943–2971.86. Marsham, P.R.; Wardleworth, G.M.; Boyle, F.T.; Hennequin, L.F., Kimbell,К.; Brown, M.; Jackman. A.L. Design and synthesis of potent non150polyglutamatable quinazoline antifolate thymidylate synthase inhibitors. J.

Med.Chem., 1999, 42, 3809-3820.87.Moreno, V.; Lorenzo, J.; Aviles, F.X.; Garcia, H.G.; Ribeiro, J.P.; Morais, T.S.;Florindo, P.; Robalo, M.P. Studies of the antiproliferative activity of ruthenium(II) cyclopentadienyl-derived complexes with nitrogen coordinated ligands.Bioinorg. Chem. Appl., 2010, 1-12.88.Ott, I. On the medicinal chemistry of gold complexes as anticancer drugs.Coord. Chem. Rev., 2009, 253, 1670-1681.89.Nobili, S.; Mini, E.; Landini, I.; Gabbiani, C.; Casini, A.; Messori, L. Goldcompounds as anticancer agents: chemistry, cellular pharmacology, andpreclinical studies. Med. Res.

Rev., 2010, 30(3), 550-580.90. G.I.Koldobskii, V.A.Ostrovskii, Russ. Chem. Rev. 63 (1994) 797.91.Ostrovskii V.A., Koldobskii G.I., Trifonov R.E. Compr. Heterocyclic. Chem.III. Eds A.R.Katritzky, C.A.Ramsden, E.F.V. Scriven, R.J.K. Taylor,V.V.Zhdankin. Oxford: Elsevier, 2008, 6, 257.92.Попова Е.А., Трифонов Р.Е. Усп. хим. 2015, 84, 891 [Popova E.A., TrifonovR.E. Russ. Chem.

Rev. 2015, 84, 891].93.Войтехович С.В., Гапоник П.Н., Григорьев Ю.В., Ивашкевич О.А.Химические проблемы создания новых материалов и технологий. 2008,117.94.Гапоник П.Н. Химические проблемы создания новых материалов итехнологий. 1998, 185.95. Гапоник П.Н., Каравай В.П., Григорьев Ю.В. ХГС. 1985, 11, 1521.96. Гапоник П.Н., Каравай В.П., Давшко И.Е., Дегтярик М.М., Богатиков А.Н.ХГС.

1990, 11, 1528.97.A.A. Bekhit, O.A. El-Sayed, T.A.K. Al-Allaf, H.Y. Aboul-Enein, M. Kunhi, S.Manogaran Pulicat , K. Al-Hussain, F. Al-Khodairy, J. Arif, Europ. J. Med.Chem. 39 (2004) 499.98. S. Komeda, Y.-L. Lin, M.A. Chikuma, ChemMedChem. 6 (2011) 987.15199.T.V. Serebryanskaya, T. Yung, A.A. Bogdanov, A.

Shchebet, S.A. Johnsen,A.S. Lyakhov, L.S. Ivashkevich, Zh.A. Ibrahimava, T.S. Garbuzenco, T.S.Kolesnikova, N.I. Melnova, P.N. Gaponik, O.A. Ivashkevich, J. Inorg. Biochem.120 (2013) 44.100.S.V. Voitekhovich, Т.V. Serebryanskaya, A.S. Lyakhov, P.N. Gaponik,O.A. Ivashkevich, Polyhedron 28 (2009) 3614.101.E.A. Popova, T.V. Serebryanskaya, S.I.

Selivanov, M. Haukka, T.L.Panikorovsky, V.V. Gurzhiy, I. Ott, R.E. Trifonov, V.Yu. Kukushkin, Eur. J.Inorg. Chem. (2016) doi: 10.1002/ejic.201600626.100. Med. Chem. 39 (2004) 499.101. M.M. Degtyarik, P.N. Gaponik, V.N. Naumenko, A.I. Lesnikovich, M.V.Nikanovich, Spectrochim. Acta 43A (1987) 349;102. V.A. Ostrovskii, G.I. Koldobskii, R.E. Trifonov in Comprehensive.Heterocyclic. Chemistry III, Vol. 6 (Eds.: A. R.

Katritzky, C. A. Ramsden, E.F. V. Scriven, R. J. K. Taylor, V. V. Zhdankin), Elsevier, Oxford, 2008. pp.259-423.103. E.A. Popova, R.E. Trifonov, Russ. Chem. Rev. 84 (2015) 891.104. Гапоник, П.Н. Металлопроизводные тетразолов / П.Н. Гапоник, С.В.Войтехович, О.А. Ивашкевич // Успехи химии.

– 2006. – Т. 75, № 6. – С.569– 604.105. R.E. Trifonov, I. Alkota, V.A. Ostrovskii, J. Elguero J. Mol. Struct.Theochem. 668 (2004) 123.][ V. A.Ostrovskii, E.A. Popova, R.E. Trifonov,Developments in Tetrazole Chemistry (2009-16), in: E.F.V. Scriven, C.A.Ramsden (Eds.), Advances in heterocyclic chemistry, Academic Press, 123,2017, pp.

2-62.106. V.A. Ostrovskii, G.I. Koldobskii, R.E. Trifonov, in: A.R. Katritzky, C.A.Ramsden,E.F.V.Scriven,R.J.K.Taylor,V.V.Zhdankin(Eds.),Comprehensive. Heterocyclic. Chemistry III, Vol. 6, Elsevier, Oxford, 2008.pp. 259-423] [R.E. Trifonov, I. Alkota, V.A.Ostrovskii, J. Elguero, J. Mol.Struct. Theochem. 668 (2004) 123.152107.

E. Arunan, G.R. Desiraju, R.A. Klein, J. Sadley, S. Scheiner, I. Alcorta, D.C.Clary, R.H. Crabtree, J.J. Dannenberg, P. Hobza, H.G. Kjaergaard, A.C.Legon, B. Menucci, D.J. Nesbitt, Pure Appl. Chem. 83 (2011) 1637.108. G.R. Desiraju, T. Steiner, Eds. The Weak Hydrogen Bond in StructuralChemistry and Biology., New York: Oxford University Press Inc, 1999.109. Thermal decompositions of 5-aminotetrazoles / A.I. Lesnikovich [et al.] //Thermochim. Acta.

– 2002. – Vol. 388. – P. 233–251110. Tao, G.-H. Energetic Nitrogen-Rich Cu(II) and Cd(II) 5,5’-Azobis(tetrazolate)Complexes / G.-H. Tao, B. Twamley, J.M. Shreeve // Inorg. Chem. – 2009. –Vol. 48. – P. 9918–9923.111. V.A. Ostrovskii, G.I. Koldobskii, R.E. Trifonov in Comprehensive.Heterocyclic. Chemistry III, Vol. 6 (Eds.: A. R. Katritzky, C. A. Ramsden, E.F. V. Scriven, R. J.

K. Taylor, V. V. Zhdankin), Elsevier, Oxford, 2008. pp.259-423.112. Richards, A.D. Synthetic metallomolecules as agents for the control of DNAstructure / A.D. Richards, A. Rodger // Chem. Soc. Rev. – 2007. – Vol. 36. – P.471–483113. Kazem Karami, Zohreh Mehri Lighvan, Ali Mohammad Alizadeh, MarziyehPoshteh-Shirani, Taghi Khayamiana and Janusz Lipkowski, RSC Adv., 2016,6, 78424–78435.114.

N. Shahabadi, S. Kashanian, K. Shalmashi, H. Roshanfekr, Appl. Biochem.Biotechnol. (2009) 158, 1-10115. Mudasir, Endang Tri Wahyuni, Daryono H. Tjahjono, Naoki Yoshioka,Hidenari Inoue SpectrochimicaActa Part A 77 (2010) 528–534.116. S. Roy, J.A. Westmaas, K.D. Hagen, G.P. van Wezel, J.

Reedijk, J. Inorg.Biochem. 103 (2009) 1288-1297.] [P. Kumar, S. Gorai, M.K. Santra, B.Mondal, D. Manna, Dalton Trans. 41 (2012) 7573-7581117. Arsene A.L., Uivaroși V., Mitrea N., Drăgoi C., Nicolae A., In vitrospectrofluorimetric analysis of the interaction of ruthenium complexes withdouble stranded calf thymus DNA, 35th FEBS Congress, June 26 - July 1,1532010, Göteborg, Suedia, rezumat publicat în F.E.B.S. Journal, 2010; 277(suppl.

1), ISSN 1742-464X, IF 3,129.118. Fox K.R., Methods in Molecular Biology. Drug-DNA interaction protocols.Humana Press, 2007; 219-230.119. TselepiE., KatsarosN., The interactionof [Ru(NH3)5Cl]2+ and[Ru(NH3)6]3+ ions with DNA. J. Inorg. Biochem., 1989; 37(4): 271-282.120. T. Topalӑ, A. Bodoki, L. Oprean, R. Oprean, Farmacia 62 (2014) 1049-1061121. C. Icsel, V.T. Yilmaz, F. Ari, E. Ulukaya, W.T.A.

Harrison, Eur. J. Med.Chem. 60 (2013) 386-394.122. N. Shahabadi, S. Kashanian, K. Shalmashi, H. Roshanfekr, Appl. Biochem.Biotechnol. 158 (2009) 1-10123. Mudasir, E.T. Wahyuni, D.H. Tjahjono, N. Yoshioka, H. Inoue, Spectrochim.Acta Part A 77 (2010) 528-534124. García-Giménez J.L., Gonzáles-Alvarez M., Liu-Gonzáles M., Macías B.,Borrás J., Alzuet G., Toward the development of metal-based syntheticnucleases: DNA binding and oxidative DNA cleavage of a mixed copper(II)complex with N-(9H-purin-6- yl)benzenesulfonamide and 1,10-phenanthroline.Antitumor activity in human Caco-2 cells and Jurkat T lymphocytes.Evaluation of p53 and Bcl-2 proteins in the apoptotic mechanism. J. Inorg.Biochem., 2009; 103: 923-934125.

Arjmand F., Parveen S., Afzal M., Shahid M., Synthesis, characterization,biological studies (DNA binding, cleavage, antibacterial and topoisomerase I)and molecular docking of copper(II) benzimidazole complexes. J. Photochem.Photobiol. B: Biology, 2012; 114: 15-26.], [T. Topalӑ, A. Bodoki, L. Oprean,R. Oprean, Farmacia 62 (2014) 1049-1061126. N.A. Kasyanenko, J. Struct. Chem.

47(1) (2006) 163-169127. P. Kumar, S. Gorai, M.K. Santra, B. Mondal, D. Manna, Dalton Trans. 41(2012) 7573-7581128. F.R. Keene, J.A. Smith, J.G. Collins, Coord. Chem. Rev. 253 (2009) 20212035.154129. M. Fanelli, M. Formica, V. Fusi, L. Giorgi, M. Micheloni, P. Paoli,Coord.Chem. Rev. 310 (2016) 41-79.130.

Urquiza NM, Naso LG, Manca SG, Lezama L, Rojo T, Williams PAM, FerrerEG. Antioxidant activity of methimazole–copper(II) bioactive species andspectroscopic investigations on the mechanism of its interaction with BovineSerum Albumin. Polyhedron. 2012;31(1):530-538.131.

Bal W, Christodoulou J, Sadler PJ, Tucker A. Multi-metal binding site ofserum albumin. J Inorg Biochem. 1998;70:33-39.132. Liu H, Shi X, Xu M, Li Z, Huang J, Bai D, et al. Transition metal complexes of2, 6-di ((phenazonyl-4-imino)methyl)-4- methylphenol structure and biologicalevaluation. Eur J Med Chem. 2011;46:1638-1647133. Sathyadevi P, Krishnamoorthy P, Jayanthi E, Butorac RR, Cowley AH,Dharmaraj N. Studies on the effect of metal ions of hydrazone complexes oninteraction with nucleic acids, bovine serum albumin and antioxidantproperties. Inorganica Chimica Acta.

2012;384:83-96.134. Samari F, Hemmateenejad B, Shamsipur M, Rashidi M, Samouei H. Affinityof two novel five-coordinated anticancer Pt(II) complexes to human and bovineserum albumins: a spectroscopic approach. Inorg Chem. 2012; 51(6):34543464135. Bovie serum albumin interactions with metal complexes,Tamara Topala,Andreea Bodoki, Luminita Oprean, Farmacy, Clujul Medical 2014 Vol. 87-4,215-219136. K. Zheng, F. Liu, Y.-T. Li, Zh.-Y. Wu, C.-W. Yan, J. Inorg.

Biochem. 156(2016) 75-88137. Peters TJ. All about Albumin: Biochemistry, Genetics, and MedicalApplications. San Diego: Academic Press; 1995.138. Vignesh G, Arunachalam S, Vignesh S, James RA. BSA binding andantimicrobialstudiesofbranchedpolyethyleneimine–copper(II)bipyridine/phenanthroline complexes. Spectrochim Acta A MolBiomol Spectrosc.

2012;96(0):108-116155139. Eftink MR, Ghiron CA. Fluorescence quenching studies with proteins. AnalBiochem. 1981; 114:199-227.140. Sathyadevi P, Krishnamoorthy P, Jayanthi E, Butorac RR, Cowley AH,Dharmaraj N. Studies on the effect of metal ions of hydrazone complexes oninteraction with nucleic acids, bovine serum albumin and antioxidantproperties. Inorganica Chimica Acta.

2012;384:83-96156.